Balyasny Asset Management LLC Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Balyasny Asset Management LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$144.95 - $152.29 $40.1 Million - $42.1 Million	276,732 Added 82.89%	610,571 $92.3 Million
Q2 2022 Aug 15, 2022	BUY	$83.14 - $145.99 $27.8 Million - $48.7 Million	333,839 New	333,839 $48.6 Million
Q4 2021 Feb 14, 2022	SELL	$99.73 - $148.48 $3.44 Million - $5.11 Million	-34,446 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$98.85 - $138.91 $3.4 Million - $4.78 Million	34,446 New	34,446 $4.79 Million
Q1 2021 May 17, 2021	SELL	$64.07 - $91.75 $873,081 - $1.25 Million	-13,627 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$65.07 - $98.24 $886,708 - $1.34 Million	13,627 New	13,627 $1.17 Million
Q4 2019 Feb 14, 2020	SELL	$40.86 - $57.65 $4.99 Million - $7.05 Million	-122,231 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$37.38 - $49.47 $930,388 - $1.23 Million	24,890 Added 25.57%	122,231 $5.1 Million
Q2 2019 Aug 14, 2019	BUY	$39.79 - $67.01 $3.87 Million - $6.52 Million	97,341 New	97,341 $4.26 Million
Q1 2019 May 15, 2019	SELL	$34.52 - $53.29 $9.14 Million - $14.1 Million	-264,861 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$29.75 - $42.9 $7.67 Million - $11.1 Million	257,659 Added 3577.6%	264,861 $9.8 Million
Q3 2018 Nov 14, 2018	SELL	$32.79 - $43.0 $229,693 - $301,215	-7,005 Reduced 49.31%	7,202 $270,000
Q2 2018 Aug 14, 2018	BUY	$23.62 - $42.29 $335,569 - $600,814	14,207 New	14,207 $561,000

785K

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.65B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Balyasny Asset Management LLC with notifications on news.